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Abstract
Although the protective effect of transient ureteral obstruction (UO) prior to ischemia on subsequent renal ischemia/
reperfusion (I/R) injury has been documented, the underlying molecular mechanism remains to be understood. We showed
in the current study that 24 h of UO led to renal tubular hypoxia in the ipsilateral kidney in mice, with the accumulation of
hypoxia-inducible factor (HIF)-2a, which lasted for a week after the release of UO. To address the functions of HIF-2a in UO-
mediated protection of renal IRI, we utilized the Mx-Cre/loxP recombination system to knock out target genes. Inactivation
of HIF-2a, but not HIF-1a blunted the renal protective effects of UO, as demonstrated by much higher serum creatinine level
and severer histological damage. UO failed to prevent postischemic neutrophil infiltration and apoptosis induction in HIF-2a
knockout mice, which also diminished the postobstructive up-regulation of the protective molecule, heat shock protein
(HSP)-27. The renal protective effects of UO were associated with the improvement of the postischemic recovery of intra-
renal microvascular blood flow, which was also dependent on the activation of HIF-2a. Our results demonstrated that UO
protected the kidney via activation of HIF-2a, which reduced tubular damages via preservation of adequate renal
microvascular perfusion after ischemia. Thus, preconditional HIF-2a activation might serve as a novel therapeutic strategy
for the treatment of ischemic acute renal failure.
Citation: Zhang S, Han C-H, Chen X-S, Zhang M, Xu L-M, et al. (2012) Transient Ureteral Obstruction Prevents against Kidney Ischemia/Reperfusion Injury via
Hypoxia-Inducible Factor (HIF)-2a Activation. PLoS ONE 7(1): e29876. doi:10.1371/journal.pone.0029876
Editor: Shree Ram Singh, National Cancer Institute, United States of America
Received August 29, 2011; Accepted December 5, 2011; Published January 25, 2012
Copyright:  2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Key Discipline Project of Renji Hospital, Shanghai Jiaotong University School of Medicine (RJ4101301) to QX. This study
was also supported by a grant from Science and Technology Commission of Shanghai Municipality (International Science and Technology Cooperation Program,
09410706300) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: xiaqiang@medmail.com.cn
. These authors contributed equally to this work.
Introduction
Ischemia and reperfusion injury (IRI) is unavoidable in renal
transplantation, and often causes acute renal failure, which is
associated with prolonged hospitalization and high mortality [1,2].
Novel effective interventional strategies not only help to improve
the clinical outcome, but also promote understanding of renal
pathophysiology.
It was reported [3] that transient ureteral obstruction (UO)
protected the kidney against the subsequent exposure to ischemia
and reperfusion (I/R) insults. This protection was not related to
uremia or humoral factors, since unilateral UO conferred
protection on the ipsilateral kidney, but not the contralateral one
[4]. The authors also reported that prior UO resulted in reduced
postischemic outer medullary congestion and leukocyte infiltra-
tion. These results were very similar to those with preconditional
activation of hypoxia-inducible factors (HIFs) [5,6].
HIFs are master regulators of oxygen homeostasis and stimulate
numerous genes important for energy metabolism, glucose
transport, vasomotor regulation, angiogenic growth and erythro-
poiesis, after activation [7,8]. HIFs are heterodimeric factors
consisting of a constitutive b subunit, HIF-1b and one of three
alternative a subunits, HIF-1a, HIF-2a, and HIF-3a [9,10].
Under normoxic conditions, HIF-a subunits have a very short
half-life. Cells continuously synthesize but rapidly degrade HIF-a
protein. Under conditions of hypoxia, HIF-a is no longer
degraded, and translocates into the nucleus, where it dimerizes
with HIF-1b to form the active HIF complex. HIF activates the
transcription of target genes by binding to hypoxia-response
elements (HREs) in their promoter or enhancer regions [11].
According to recent reports [12], the most widely expressed and
best characterized a subunit in the hypoxic/ischemic kidney is
HIF-1a, and its expression has been described in both tubular and
glomerular epithelial cells. HIF-2a is also induced in the hypoxic
kidney, but is localized in glomerular cells, endothelial cells, and
fibroblasts [13,14]. Importantly, HIF-1a and HIF-2a appear to
regulate distinct subsets of target genes [15].
It has been reported [16] that UO kidneys are hypoxic and
display protein and gene expression changes consistent with HIF
activation, the role of which in the protection of renal IRI has not
been clearly defined so far. In this study, we inactivated HIF-1a
and HIF-2a genes by the Cre-loxP conditional gene disruption
system to create HIF-1a or HIF-2a knockout mice, as well as HIF-
1a/2a double knockout (DKO) mice, and subjected them to
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the renoprotective effects of UO.
Materials and Methods
Ethic statements
All animal experiments have been conducted according to
standard use protocols, animal welfare regulations and the
institutional guidelines of Shanghai Jiaotong University School of
Medicine and the Regulations for Practice of Experimental
Animals (issued by Scientific and Technical Committee,
P.R.China, 1988). All the procedures described were approved
by the Animal Use and Care Committee of Shanghai Jiaotong
University School of Medicine (approval number: SYKX-2008-
0050). All surgery was performed under sodium pentobarbital
anesthesia. Analgesia used was bupivacaine(0.5%), a long acting
local analgesic, immediately after surgery and only once. Several
drops of bupivacaine were dripped on the suture line after the
muscle layer was closed, and before the closure of skin wound. All
these efforts were made to minimize suffering.
Mice
The Cre/loxP recombination system was used to generate HIF-
1a
2/2, HIF-2a
2/2, or HIF-1a/2a double knockout mice. Mice
containing loxP-flanked HIF-1a exon 2 (HIF-1a
loxP/loxP, stock
number: 007561), loxP-flanked HIF-2a exon 2 (HIF-2a
loxP/loxP,
stock number: 008407) and Mx promoter sequence-modified Cre
recombinase gene (Mx-cre, stock number: 003556) were from the
Jackson Laboratory (Bar Harbor, Maine USA). After a mating of
HIF-1a
loxP/loxP and Mx-cre strains and a second mating of their
progeny, mice that were homozygous for the HIF-1a floxed allele





loxP/loxP mice were then backcrossed to
the Mx
2HIF-1a
loxP/loxP mice to generate both Mx
+ mice
(deletable) and Mx
2 littermates (nondeletable). To mutate the
target gene, 8-week old mice were administered intraperitoneal
injections of 400-mg poly deoxyinosinic/deoxycytidylic acid (pIpC)
every 4 days for a total of three injections. Mx
+HIF-1a
loxP/loxP
mice that had received injections of pIpC were hereafter referred
to as HIF-1a
2/2 mice. The generation of HIF-2a
2/2 mice and the





loxP/loxP mice that had received injections of pIpC
served as controls in all the following experiments and were referred
to as wild-type (WT) mice.
Mx
+HIF-1a
loxP/loxP mice were then mated with Mx
+HIF-
2a
loxP/loxP mice. After a second mating of their progeny, mice that
were homozygous for both HIF-1a and HIF-2a floxed allele and




loxP/loxP mice that had received
injections of pIpC were deficient in both HIF-1a and HIF-2a
genes, hereafter were referred to as double knockout (DKO) mice.
Male mice, 8–14 weeks of age and weighing 20–28 g, were used
in the present study.
Genotyping
Genomic DNA was isolated from tail biopsies. Genotyping was
performed using PCR which had been described previously. The
HIF-1a
loxP/loxP and the wild-type alleles were detected using the
following primers: 59- GGAGCTATCTCTCTAGACC -39 and
59- GCAGTTAAGAGCACTAGTTG -39, which generated a
250 bp product in floxed allele and 215 bp product in wild type
[17]. To distinguish HIF-2a
loxP/loxP mice from wild type by
multiplex PCR, the primers were as follows: P1: 59-CAGGCAG-
TATGCCTGGCTAATTCCAGTT-39; P2: 59-CTTCTTCCAT-
CATCTGGGATCTGGGACT-39; P3: 59-GCTAACACTGTA-
CTGTCTGAAAGAGTAGC-39. The wild type allele produced a
410-bp fragment (P1 and P2), the 2-loxP allele produced a 444-bp
fragment (P1 and P2), and the 1-loxP allele produced a 340-bp
fragment (P1 and P3) [18]. The Mx-cre transgene was detected
using the primers 59-ACCTGAAGATGTTCGCGATTATCT-
39, and 59-ACCGTCAGTACGTGAGATATCTT-39, which
amplified a 370-bp fragment [19].
Transient unilateral ureteral obstruction (UO)
A transient UO procedure was used as described [3], with
modifications. After anesthesia a midline laparotomy was made.
The left ureter was identified and surrounded by a 7-0 silk suture
1 cm below its renal origin, and then was ligated by tying a one-
loop shoelace knot. The right ureter was left undisturbed. The
suture end, which was left outside the abdominal wall after the
incision was closed, would be slipped and removed 24 h after the
operation to release the ureter from obstruction. 0 (immediately),
2, 4 or 7 days after release of obstruction, these mice were
subjected to renal I/R insults. Sham controls underwent the same
surgical procedures but without tying the knot, hereafter were
referred to as non-UO controls.
Renal ischemia-reperfusion model (IR)
Anesthesia was induced with sodium pentobarbital (60 mg/kg
body weight i.p.). Mice were placed on a temperature-controlled
heating table with a rectal thermometer probe attached to a
thermal feedback controller (ALC-HTP Homeothermic System,
Shanghai Alcott Biotech Co. Ltd, China) to maintain rectal
temperature at 36uC. A warm renal IR model was used as
described [20], with minor modifications. In brief, following a
midline abdominal incision, right nephrectomy was performed.
After intraperitoneal injection of heparin (50 U/kg), left renal
pedicle was localized and clamped for 25 min using an atraumatic
micro-vascular clamp. After inspection for signs of ischemia,
animals were covered with surgical dressing to keep stable
intraperitoneal temperature. After removal of the clamp, restora-
tion of blood flow was inspected visually. Sham controls
underwent same surgical procedures but without vascular
occlusion, hereafter were referred to as non-IR controls. Animals
were killed 6 h or 24 h after reperfusion by exsanguination, to
obtain blood and renal samples for further analyses.
Tissue oxygen partial pressure (tPO2) measurements and
laser doppler flowmetry (LDF) monitoring in kidneys
A large-area-surface O2 probe, which was connected to a tissue
oxygen monitoring system (OxyLab pO2 system, Oxford Op-
tronics, UK), was used for tPO2 monitoring in mouse kidneys, as
described previously [21,22]. Measurements were performed in
both kidneys 24 h after left UO, without release of obstruction.
The inferior pole of the kidney was punctured using a 22-gauge
needle and the O2 probe was inserted to a depth of 3 mm. Since
the O2 probe measured oxygenation along the shaft of the
catheter, i.e., away from the tip, it was actually sampling from a
depth of 2 mm. We established in preliminary experiments that
such an insertion depth enabled measurement of tPO2 within
renal outer medulla. The measurement began 30 minutes after the
probe was inserted and continued for 10 minutes. The values of
ten minutes collected by the probe were expressed as a mean pO2
value (mmHg) over the period of observation. The core
temperature was maintained at 36uC throughout the procedures.
It’s worth notice that core body temperature control is very
important to the measurement. The oxygen tension levels vary a
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temperature.
For renal tissue blood perfusion monitoring, a pO2/Flow Bare-
Fibre sensor, which was connected to an OxyLab LDF instrument
(Oxford Optronix, UK), was inserted into renal outer medulla to
enable monitoring of continuous microvascular blood flow, as
described previously [22]. The measurement began 30 minutes
after the probe was inserted and continued for 10 minutes with the
core temperature maintained at 36uC. The values of ten minutes
collected by the probe were expressed as a mean value of blood
perfusion units (BPU) over the period of observation. Baseline
renal blood flow was obtained by monitoring the microvascular
blood flow in the right kidney before UO or sham procedures.
After the initiation of reperfusion, the blood flow in the left kidney
was measured at the indicated time points, and the mean value
versus the baseline result was defined as relative renal perfusion.
Biochemical analyses
Arterial blood was collected by direct puncture of arteriae aorta.
Serum creatinine (Cr) was measured with a standard clinical
automatic analyzer (Siemens Dade behring dimension xpand).
Histology and histomorphological scoring of acute
tubular injury
Kidney tissues were fixed in 10% neutral buffered formalin
overnight, dehydrated, embedded in paraffin and sectioned at
5 mm. For histological analysis, sections were stained with Periodic
Acid-Schiff (PAS). Samples were analyzed for tubular cell necrosis,
tubular dilation, intratubular cell detachment, and cast formation
(original magnification 6200) and were all evaluated in a blinded
manner by a nephropathologist. Abnormalities were graded by a
semiquantitative histomorphological scoring system from 0 to 4, as
described previously [23]. At least 3 fields per section were
evaluated.
Polymorphonuclear leukocyte infiltration (MPO activity)
Renal sections were processed for immunohistochemical
localization of myeloperoxidase (MPO, polyclonal rabbit antibody;
Novus Biologicals, NBP1-42591), and were then visualized with
diaminobenzadine (DAB) and counterstained with hematoxylin.
Polymorphonuclear leukocyte (PMN) infiltration was scored
semiquantitatively on a scale of 1 (none) to 4 (severe), as described
previously [24].
Terminal deoxynucleotidyl transferase-mediated 29-
deoxyuridine 59-triphosphate nick-end labeling assay
(TUNEL)
Apoptotic cells in formalin-fixed, paraffin-embedded kidney
tissue sections were identified with ApopTag
TM Fluorescein In
Situ Apoptosis Detection Kit S7110 (Chemicon International),
according to the manufacturer’s protocol. Cells with nuclear
positive staining by fluorescent antibodies for DNA fragmentation
were visualized directly by a fluorescence microscopy and counted
(original magnification 6400). At least 3 fields per section were
examined.
Quantitative western blot analysis
Western blot analysis of HIF-1a and HIF-2a was performed as
described previously [25]. Nuclear extracts were isolated from
harvested whole kidneys using NE-PER Nuclear and Cytoplasmic
Extraction Reagents (Product Number 78833, Pierce Biotechnol-
ogy, Inc., USA.), supplemented with Complete Protease Inhibitor
Cocktail Tablets (Roche, Indianapolis, IN). Nuclear protein
fractions were electrophoresed on 10% SDS-PAGE under
reducing conditions and transferred to a nitrocellulose membrane
(Whatman) by standard procedures. Membranes were blocked
with LI-COR blocking buffer (LI-COR Biosciences, Lincoln, NE).
Membranes were then incubated with the same blocking solution
containing rabbit polyclonal primary antibodies against HIF-1a
(1:500, NB100-479, Novus Biologicals) and HIF-2a (1:500, ab199,
Abcam). After washing, membranes were incubated at room
temperature for 1 h in TBS/0.05% Tween 20 buffer with the
IRDye800 secondary antibodies (1:10000; LI-COR Biosciences)
and then washed again in TBS/0.05% Tween 20 for 3 times. The
blot was visualized using an Odyssey infrared imaging system (LI-
COR Biosciences). Samples were corrected for background and
quantified using Odyssey software. All values were normalized to a
loading control TATA binding protein (TBP, 1:2000, ab818,
Abcam) and expressed as fold increase relative to control.
For heat shock protein (HSP)-27 measurements, harvested
kidneys were homogenized and lysed with cell lysis buffer, which
contained 1 protease inhibitor cocktail tablet per 10 mL of Lysis
Reagents (Complete; Roche, Indianapolis, IN). Solutions were
then clarified by centrifugation (25 minutes at 16,000 g). Solubi-
lized proteins were then resolved on a 10% SDS-polyacrylamide
gel and transferred to nitrocellulose membranes (Whatman). After
blocked with LI-COR blocking buffer, blots were incubated with
anti-HSP-27 (1:500, #2442, Cell Signaling Technology, Inc.) and
anti-b-actin (1:2000, Santa cruz biotechnology, inc.) antibodies.
After incubation with secondary antibodies, blots were developed
as described above. HSP-27 expression levels were normalized to
b-actin expression levels.
Statistics
All values were reported as the mean 6 standard deviation
(SD). Data were analyzed with a one-way ANOVA with
subsequent Student-Newman-Keul’s test or Student’s t-test where
applicable. Statistical significance was set at P,0.05.
Results
UO led to renal tubular hypoxia
Since UO causes blockage of urine flow from the kidney and
thus induces a high pressure state within the intrarenal
Figure 1. Effect of 24 h UO on renal tissue oxygen partial
pressure (tPO2) level. WT mice were subjected to either non-UO
sham surgery or left UO. After 24 hours, bilateral renal tPO2
measurements were performed without release of UO. There were 5
mice in each group. Values were expressed as mean 6 SD. *, p,0.05
versus the other three groups. L, left kidney; R, right kidney.
doi:10.1371/journal.pone.0029876.g001
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balance between local oxygen supply and consumption, and lead
to hypoxia. To confirm this, we employed OxyLab pO2 system,
which had a proven record of success in a variety of applications
[26–30], to evaluate the renal tissue oxygenation after UO.
The left and right kidneys in non-UO control mice manifested
similar tissue oxygen tensions in outer medulla 24 h after the sham
operation, which were comparable with the baseline levels derived
from those without prior operations (data not shown). Left UO
didn’t change the tPO2 level in the right kidney, but led to a fall
from 28.5461.47 to 19.3562.67 mmHg of the oxygen tension in
the ipsilateral kidney 24 hours later (Figure 1).
24 hours of UO caused an accumulation of HIF-2a, but
not HIF-1a
To determine whether the hypoxic state induced by UO could
lead to accumulation of HIF-1a and HIF-2a, and how long this
accumulation could persist after release of obstruction, we
evaluated renal HIF-1a and HIF-2a protein levels by quantitative
western blot analyses on day 0 (immediately), day 2, day 4 and day
7 after release of obstruction.
Kidneys from non-operated controls or non-UO sham-
operated mice had barely detectable levels of HIF-1a and
HIF-2a, whereas left kidneys from UO mice had much higher
HIF-2a levels on day 0 (24 h after initiation of obstruction),
w h i c hw e r ee v e nf u r t h e ru p - r e g u l a t e do nd a y2 ,a n dt h e n
decreased on day 4. One week after release of UO, HIF-2a was
still maintained at a relatively high level (Figure 2). HIF-1a levels
remained unchanged, similar to those of non-UO controls at all
tested time points. These results suggested that renal hypoxia
resulted from UO selectively up-regulated HIF-2a and the
biological effects of UO might be mediated by HIF-2a, rather
than HIF-1a.
Inactivation of HIF-2a, rather than HIF-1a, neutralized the
renoprotective effects of UO
Inactivation of target genes was confirmed by immunoblot
analyses. The accumulation of HIF-2a in kidney after UO or UO
plus I/R procedures was largely diminished by the Mx-Cre/loxP
recombination system (Figure 3). To confirm whether UO
provided protection against IRI after release of obstruction in
WT mice, as described previously [3], renal pedicle of the
Figure 2. Effect of 24 h UO on renal HIF-1a/2a expression. WT mice were exposed to either sham-operation or left UO, which continued for
24 hours, and then was released. The left kidneys were harvested immediately (d0), 2, 4 or 7 days after release of obstruction (n=4 at each time
point). Immunoblot analyses of HIF-1a and HIF-2a in left kidneys were then performed and co-detection of TBP was performed to assess equal
loading. HIF protein bands were quantified and normalized to TBP. Data were expressed as mean 6 SD, and the mean value obtained from non-
operated control mice was arbitrarily defined as 1. *, p,0.05 versus sham-operated controls; **, p,0.05 versus all the other groups. C, non-operated
controls; S, sham-operated controls.
doi:10.1371/journal.pone.0029876.g002
Figure 3. HIF-2a levels in HIF-2a
2/2 and WT mouse kidneys. A, HIF-2a
2/2 mice or their wild-type littermates were exposed to left UO, which
continued for 24 hours, and then was released. 2 days after release of UO or at the corresponding time point in the non-UO sham-operated mice, the
left kidneys were harvested and subjected to immunoblot analyses of HIF-2a and co-detection of TBP as a loading control. B, Mice were also exposed
to I/R procedures before the harvest of the left kidneys to evaluate the HIF-2a levels 6 hours after the initiation of reperfusion. HIF-2a protein bands
were quantified and normalized to TBP. There were 4 mice in each group and data were expressed as mean 6 SD. The mean value obtained from
sham-operated WT mice was arbitrarily defined as 1. *, p,0.05 versus all the other 3 groups.
doi:10.1371/journal.pone.0029876.g003
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nephrectomy, and then was allowed for 24 h of reperfusion.
Compared with non-UO controls, UO significantly improved
renal function, as indicated by much lower serum Cr concentra-
tions (Figure 4A). Ischemia imposed at all tested time points after
release of UO resulted in significant decrease in Cr levels, but the
profoundest decrease was seen on day 2. This was in line with the
HIF-2a induction pattern after UO. To investigate the role of
HIFs in the protective effects of UO, HIF-1a
2/2, HIF-2a
2/2 and
DKO mice were subjected to the same procedures as described
above. Although all these mice manifested similar Cr levels to WT
mice without UO procedures, UO preconditioning led to
discrepancies among different strains. HIF-1a
2/2 mice also
benefited from UO as WT mice did, but HIF-2a
2/2 and DKO
mice were much more susceptible to IR injury after UO.
The result of Cr levels was reinforced by histological
observations. Tubular damage was assessed by PAS staining.
Both WT and HIF-1a
2/2 mice that were subjected to UO plus IR
manifested much mitigated tubular injury, compared with non-
UO plus IR renal sections. In contrast, both HIF-2a
2/2 and
DKO mice had much severer renal damage, even though they
were also pretreated with UO (Figure 4B). Histological abnor-
malities of renal sections from all tested time points after UO were
scored and shown in Figure 4C. UO preconditioning significantly
decreased histological scores in WT and HIF-1a
2/2 sections,
whereas the effects of UO were neutralized to a great extent by
HIF-2a or double knockout. Histomorphological scores of tubular
damage correlated well with the serum Cr results.
These results demonstrated that renal resistance against
ischemia conferred by UO was dependent on the timing of
Figure 4. UO-mediated renoprotective effects were negated by HIF-2a knockout. Mice were exposed to either non-UO sham-operation or
left UO, which continued for 24 hours, and then was released. At different time points (0 d, 2 d, 4 d, 7 d) after release of UO, animals were subjected
to right nephrectomy, followed by IR (25 min of left renal ischemia and 24 h of reperfusion) or non-IR sham operation. A, concentrations of serum
creatinine 24 h after the initiation of reperfusion. B, representative renal PAS-stained sections from mice of UO 2 d group and their non-UO controls
(original magnification6200). Sections from HIF-1a
2/2, HIF-2a
2/2 and DKO mice in non-IR groups had no positive manifestations (similar to those of
WT non-IR mice) and were not shown. C, abnormalities based on PAS-stained sections was graded by a semiquantitative histomorphological scoring
system from 0 to 4. All mice in non-IR groups had no tubular damage (histomorphological score: 0, data not shown). Data were expressed as mean 6
SD from 6–8 animals per genotype. *, p,0.05 versus WT mice that were treated with the same procedures.
doi:10.1371/journal.pone.0029876.g004
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accumulation of HIF-2a. And HIF-2a, rather than HIF-1a
knockout neutralized most protective effects of UO. Thus the
renoprotective effects of UO should be attributed to the
transcriptional responses induced by HIF-2a, rather than HIF-1a.
The role of HIFs in UO-mediated reduction of
postischemic neutrophil infiltration
IR results in neutrophil recruitment, and neutrophil-mediated
renal injury is an important component of renal IR injury [31].
Previous report [3] has indicated that the protective effects of UO
were related to a reduction of the postischemic tissue MPO
activity. To clarify the role of HIFs in this process, renal sections
from different strains were also immunostained for MPO activity.
Figure 5 showed that prior UO prevented most of the postischemic
increase in MPO activity in WT mice, as well as in HIF-1a
2/2
mice. This dissociated HIF-1a from UO mediated reduction of
neutrophil infiltration. However, HIF-2a or double knockout
negated the effects of UO on MPO activity, indicating that HIF-
2a played a big part in reducing neutrophil infiltration.
The role of HIFs in UO-mediated prevention of apoptosis
To evaluate the role of HIFs in apoptosis induction in the setting
of UO-mediated renoprotection, TUNEL assay was used to detect
apoptotic cells in renal sections from different strains of mice. Renal
IR without UO induced similar degrees of apoptosis in all the
strains, showing that without pretreatment, neither HIF-1a nor
HIF-2a participated in apoptosis induction or prevention. Apo-
ptotic cells werereduced to a great extent by UO preconditioningin
WT and HIF-1a
2/2 mice. However, UO didn’t manifest such an
obvious effect in HIF-2a
2/2 or double knockout mice (Figure 6A).
The degree of renal tubular apoptosis was also quantified and
graphically presented inFigure6B, toshow theoverall effects ofUO
on apoptosis prevention at all tested time points.
Postobstructive expression of HSP-27 was compromised
by HIF-2a knockout
The up-regulated expression of HSP-27 by UO, and the
protective effects of HSP-27 on renal IRI have been described
[3]. However, the regulatory mechanism of HSP-27 overexpression
inthissetting hasnotbeen establishedsofar.Togaininsightintothe
relationship between HIFs and HSP-27, we analyzed renal
expression of HSP-27 in wild-type and the genetically engineered
mice 2 days after release of UO, as well as 6 hours after ischemic
insult. As compared with non-UO controls (Figure 7A), UO led to
markedly up-regulated HSP-27 levels in WT and HIF-1a
2/2 mice,
but failed to induce the same expression enhancement in HIF-2a
2/
2 and DKO mice (Figure 7B). Moreover, while IRI without UO
failed to induce different HSP-27 levels among the four groups
(Figure 7C), a marked up-regulation of postischemic HSP-27
level was observed in WT and HIF-1a
2/2 kidneys that were
treated with UO plus IR procedures. However, in HIF-2a
2/2
Figure 5. Effect of UO on post-ischemic polymorphonuclear
leukocyte (PMN) infiltration in different strains. At different time
points (0 d, 2 d, 4 d, 7 d) after release of UO, animals were subjected to
renal IR, and then the left kidneys were harvested and immunostained
for MPO activity. A, representative renal sections from mice of UO 2 d
group and their non-UO controls (original magnification 6200).
Sections from HIF-1a
2/2, HIF-2a
2/2 and DKO mice in non-IR groups
had no PMN infiltration and were not shown. B, PMN infiltration was
scored on a scale of 1–4. The results of different strains at all tested time
points were presented. All mice that were subjected to non-IR sham
operation had no PMN infiltration and the results were not shown. Data
were expressed as mean 6 SD from 6–8 animals per genotype. *,
p,0.05 versus WT mice that were treated with the same procedures.
doi:10.1371/journal.pone.0029876.g005
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postischemic HSP-27 level (Figure 7D).
UO led to much better postischemic recovery of renal
blood flow, which was totally negated by HIF-2a
knockout
To assess the possibility that UO and HIF-2a may act to protect
the vascular function and facilitate renal microcirculation
following ischemia, renal blood flow in the outer medulla was
measured in WT and HIF-2a
2/2 mice after the initiation of
reperfusion. Baseline microvascular flow, which was obtained from
the right kidneys prior to UO or sham operations, was comparable
between WT and HIF-2a
2/2 mice. As shown in Figure 8A, after
the initiation of reperfusion, renal blood flow didn’t recover to the
baseline level until 12 hours after reperfusion. But in those with
UO preconditioning the blood flow recovered so fast that we
called it ‘‘an immediate recovery’’. However, the ‘‘immediate
recovery’’ can only be seen in WT mice. No differences could be
observed between UO and sham groups in HIF-2a knockout mice
(Figure 8B). These data suggested that HIF-2a was not a regulator
of basal renal hemodynamics, but preconditional activation of
HIF-2a helped the endothelium to face the acute ischemic
challenge and greatly improved the reperfusion efficiency.
Discussion
Since ischemic acute renal failure continues to be associated
with a very high mortality rate in humans, it is important to
understand the endogenous processes the kidney uses to protect
itself. Several studies provided evidences for a critical role of HIF-1
in the protective effects of ischemic preconditioning in multiple
organs [32–34]. It was also reported [5,35] that preconditional
pharmacological or genetical activation of HIFs before patholog-
ical insult activated a self-defense mechanism and ameliorated
ischemic acute renal failure. Park et al. reported [3] that prior
transient UO led to markedly alleviated injury in subsequent renal
I/R, but the authors did not correlate this phenomenon with the
activation of HIFs. It was known that UO was associated with a
reduction in renal blood flow and resulted in renal tubular hypoxia
[36,37], and it was also reported [16,38] that UO led to activation
of HIFs. So we had reasons to speculate that the renoprotective
effects conferred by UO might be associated with activation of
HIFs. Since the transcriptional response to hypoxia was primarily
mediated by two hypoxia-inducible factors, HIF-1 and HIF-2, we
set out to explore the role of the two HIFs in the renoprotective
effects of UO.
We first determined whether transient ligation of the ureter
could cause renal hypoxia and accumulation of HIF-a protein in
kidney tissues. Previous report [16] has suggested that UO was
associated with a reduction in renal tubular oxygen tensions
24 hours after ligation. In that study tissue hypoxia was detected
using pimonidazole hydrochloride, which formed protein adducts
only in cells that experienced an oxygen level of approximately 1%
O2, or lower. Here we used a quantitative method, which was
based on the principle of oxygen quenching of fluorescence, to
Figure 6. Effect of UO on apoptosis induction in different
strains. A, TUNEL assay showed positive nuclear staining by
fluorescent antibodies for DNA fragmentation in apoptotic cells in
representative renal sections from mice of UO 2 d group and their non-
UO controls (original magnification 6400). Sections from sham-
operated (non-IR) HIF-1a
2/2, HIF-2a
2/2 and DKO mice manifested no
positive staining (data not shown). B, a summary of the quantitative
analysis of apoptotic cells per field. All mice that were subjected to non-
IR sham operation had no apoptotic cells (data not shown). Data were
expressed as mean 6 SD from 6–8 animals per genotype. *, p,0.05
versus WT mice that were treated with the same procedures.
doi:10.1371/journal.pone.0029876.g006
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The results demonstrate that 24 h of UO leads to a mild hypoxic
state in the ipsilateral kidney, and thus transient UO and the
following recanalization put the kidney through a hypoxia and re-
oxygenation cycle, which makes UO an atypical kind of hypoxic
preconditioning.
Although previous study [16] has demonstrated stabilization of
HIF-1a and HIF-2a protein in UO kidneys, a kind of continuous
UO, which lasted for 8 days, rather than transient UO, was
employed in that study. Our data revealed that transient UO,
which lasted for only 24 hours, triggered a robust and long-lasting
HIF-2a (rather than HIF-1a) accumulation, which continued for
over a week and peaked on day 2 after release of obstruction.
Previous sublethal hypoxia induces tolerance to subsequent
hypoxic/ischemic insults in a process known as ischemic
preconditioning or hypoxic preconditioning, in which HIF-1 has
been well confirmed as a key transcription protein [32,39]. HIF-2
has seldom been reported to engage as a participant in hypoxic
preconditioning. Our results demonstrate that prior transient UO,
as an atypical kind of hypoxic preconditioning, also features
activation of an atypical molecular mediator.
To gain further insight into the role of HIFs in UO-related renal
protection and to establish whether this relation is causal, we used
a well established model of unilateral renal I/R in mice with
conditional knockout of HIF-a isoform(s). As was reported, prior
transient UO resulted in profound protection against ischemic
injury after release of obstruction in WT mice. Inactivation of
HIF-2a, rather than HIF-1a, greatly neutralized the renoprotec-
tive effects of UO, as indicated by higher creatinine level, severer
histological damage and leukocyte infiltration, much more
apoptotic cells, as compared with those in WT and HIF-1a
2/2
mice. HIF-1a/2a double-knockout mice manifested quite similar
degree of injury to HIF-2a
2/2 mice, showing that there wasn’t a
compensatory effect between HIF-1a and HIF-2a in this setting.
But why is HIF-2a, rather than HIF-1a up-regulated and
playing a key role in this setting? The tPO2 measurements have
shown that UO decreases the renal tissue oxygen level from
approximately 30 mmHg to 20 mmHg. So, unlike ischemic
preconditioning, which involves total cessation of renal blood
flow, UO is a kind of ‘‘long-lasting but mild’’ hypoxic
preconditioning. It has been reported [40] that HIF-2a stabiliza-
tion can be detected in well-vascularized regions and at higher O2
tensions (5%, mild hypoxia) than HIF-1a (below 1%, extreme
hypoxia). The temporal patterns of the two HIF-a subunit
accumulation are also different. HIF-1a is stabilized acutely,
whereas HIF-2a protein gradually accumulates and remains
stabilized over longer periods of hypoxia, governing prolonged
hypoxic gene activation. While HIF-1a and HIF-2a share
significant sequence homology, have similar domain architecture
and undergo the same proteolytic regulation [41], this study in the
context of UO-mediated renoprotection again demonstrates
significant differences in the biological characteristics of these
two isoforms.
Our results also demonstrated that without UO precondition-
ing, HIF-1a or 2a knockout didn’t lead to altered ischemic renal
damage. This was inconsistent with previous observations which
demonstrated that a genetic reduction in HIF-1a or HIF-2a led to
severer injury [42,43]. This may be explained by the different gene
targeting techniques that were employed. In the previous reports,
a systematic knockdown of target genes by standard gene targeting
in ES cells led to heterozygous deficiency for HIF-1a or HIF-2a
throughout ontogeny, which may lead to developmental defect,
especially in vasculature. However, in this study the gene
inactivation was induced by pIpC injection in adult animals, and
Figure 7. Effect of HIF-1a/2a inactivation on postobstructive and postischemic expression of HSP-27. Western blot analysis of HSP-27 in
left kidneys of mice subjected to non-UO sham operation (A) or 24 h UO followed by recanalization (2 days) (B). Additional mice were subjected to
non-UO procedures, followed by 25 min of left renal ischemia and 6 h of reperfusion (C), or UO 2 d, followed by the same IR procedures (D).
Codetection of b-actin was performed to assess equal loading. Protein bands were quantified, and the relative density of protein bands obtained
from sham-operated WT mice was arbitrarily defined as 1. Graph showed data acquired from 4 independent experiments for each mouse strain. *,
p,0.05 compared with WT mice.
doi:10.1371/journal.pone.0029876.g007
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50,60% in the kidney, which comprised a relatively small
proportion of interferon-responsive cells [44]. So, although this
technique led to homozygous deficiency for target genes in
interferon-responsive cells, there were still quite a proportion of
renal cells with intact target genes.
HSP-27 functions as an anti-apoptotic molecule and prevents
cell death by a wide variety of agents that cause apoptosis [45].
HSP-27 also reduces the inflammatory responses by decreasing
production of cytokines and adhesion molecules, reducing
leukocyte-endothelial interactions, and mitigating congestion in
the outer medulla [3]. Selective renal overexpression of human
HSP-27 reduces renal IRI [46]. So, HSP-27 plays a role in the
protection against IRI [47,48]. However, expression of HSP-27 is
only transiently induced in response to the stress events, after
which expression levels fall drastically, thus allowing only for
overexpression when its cytoprotective properties are required.
Park et al. reported that UO induced an increase of HSP-27
expression [3]. But why HSP-27 was up-regulated after UO has
not been clarified. HSP-27 was reported to be regulated by
hypoxic signaling through HIF-1 activation in the retina and to
protect the retina from ischemic injury [49]. Our results are
significant, not only because we reconfirmed the relation between
HIF and HSP-27 expression in another organ, but also because it
was the first time HIF-2 activation was demonstrated to be also
associated with HSP-27 up-regulation. Although HSP-27 may
take a big part in UO-mediated renoprotection, it is unlikely that
HSP-27 alone is responsible for all the protective effects. Further
studies should clarify whether HIF-regulated hypoxia responsive
genes besides HSP-27 are increased in the kidney in response to
acute urinary tract obstruction, and whether they are vital to the
prevention of renal IRI.
As was reported, HIF-2a was not expressed in renal tubular
cells, but in peritubular endothelial cells and fibroblasts [13,14].
Then how does HIF-2a protect against renal tubular damage?
Although the renal tubular epithelial cell injury that occurs
during an ischemic event undoubtedly plays a key role in ischemic
renal injury, there is growing evidence that renal vascular
endothelial injury and dysfunction are even more important
factors in initiating and extending renal tubular epithelial injury
[50,51]. Lack of adequate renal cortical-medullary reperfusion
may be more deleterious than the classical ‘‘reperfusion injury’’
secondary to oxygen and nitrogenous free radical formation
[52,53]. Medullary endothelial cell injury and dysfunction may
also contribute to the inflammatory response, because endothelial
cells in the medullary region, but not the cortex, express surface
markers important in lymphocyte activation [54].
Measurement of blood flow changes in the microcirculation
using LDF has well proved to be a reliable method for the
assessment of endothelial function [55,56]. So, to explore the
possible influence of UO upon postischemic renal endothelial
function and the role of HIF-2a in this setting as well, we used
LDF to evaluate the renal microcirculatory recovery after I/R
insult. In WT mice with UO preconditioning, blood flow in renal
outer medulla approached the pre-ischemic level much more
rapidly than those without UO pretreatment. However, inactiva-
tion of HIF-2a totally negated the effects of UO preconditioning,
indicating that activation of HIF-2a by UO reduced renal IR
injury via preservation of vital vascular functions and medullar
blood flow.
Based on initial reports showing high levels of expression of
HIF-2a mRNA in endothelial cells and some highly vascularized
tissues, HIF-2a was also referred to as endothelial PAS domain
protein 1 (EPAS1) [57]. HIF-2a is actually very important for
hypoxic adaptation of the vasculature, which is supported by the
observations that HIF-2a has a stronger transactivation activity
than HIF-1a on the promotor of vascular endothelial growth
factor (VEGF) [58,59], and overexpression of HIF-2a, but not
HIF-1a, was found to enhance expression of the endothelial
tyrosine kinase receptor Tie2 [57,60]. We have correlated HIF-2a
activation with up-regulated HSP-27. In fact, an increase in the
HSP-27 levels in infected endothelial cells has been demonstrated
to correlate well with their resistance to apoptosis under
reoxygenation [61].
Previous report [43] using systematic but heterozygous HIF-2a
knockdown mice has demonstrated that in the setting of renal IR,
there was a specific role of HIF-2a in endothelial cells, but not in
inflammatory cells. The authors indicated that HIF-2a knockdown
mice were more susceptible to renal IRI, because of peritubular
capillary loss and decreased expression of antioxidative stress genes
Figure 8. Effect of UO on postischemic recovery of intra-renal
microvascular blood flow in WT and HIF-2a
2/2 mice. WT (A) or
HIF-2a
2/2 mice (B) were subjected to either non-UO sham surgery or
left UO, before which baseline renal blood flow was obtained by
monitoring the microvascular blood flow in the right kidney. 2 days
after release of obstruction, the left kidney was subjected to 25 min of
ischemia immediately after right nephrectomy was performed. After the
initiation of reperfusion, the blood flow in the left kidney was measured
at the indicated time points, and the mean value versus the baseline
value was defined as relative renal perfusion. Graph showed data
acquired from 4–6 independent experiments for each mouse strain at
each time point. *, p,0.05 between UO-IR and sham-IR groups.
doi:10.1371/journal.pone.0029876.g008
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induced in endothelial cells[62], and thus floxed target genes can
be inactivated homozygously in renal endothelial cells in adults by
the Mx-Cre/loxP recombination system [63] without damaging
vascular development, these results give further evidence of the
crucial role of HIF-2a in the protection against endothelial
dysfunction in acute ischemic renal injury.
These results have significant research implications. Since 24 h
of UO leads to HIF-2a stabilization without the induction of HIF-
1a, UO can be widely employed in the research work concerning
the role of HIF-2a in various renal diseases besides ischemic acute
renal failure, for example, nephrotoxic acute kidney injury,
radiocontrast nephropathy, and acute glomerulonephritis. Our
findings may also be of importance to clinical practice. Although
UO is not a feasible way to reduce clinical renal IRI, the strong
protective effects of UO can be obtained by pharmaceutical
activation of HIF-2a. And since the two HIFs can be stabilized
under different conditions and mediate different adaptive
responses to hypoxia, it might be a viable therapeutic option that
exogenous influences could be developed to mimic both processes
and create a synergistic effect in attenuating renal IRI.
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